330 related articles for article (PubMed ID: 28273791)
1. Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).
Ansseau E; Vanderplanck C; Wauters A; Harper SQ; Coppée F; Belayew A
Genes (Basel); 2017 Mar; 8(3):. PubMed ID: 28273791
[TBL] [Abstract][Full Text] [Related]
2. The FSHD atrophic myotube phenotype is caused by DUX4 expression.
Vanderplanck C; Ansseau E; Charron S; Stricwant N; Tassin A; Laoudj-Chenivesse D; Wilton SD; Coppée F; Belayew A
PLoS One; 2011; 6(10):e26820. PubMed ID: 22053214
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
[TBL] [Abstract][Full Text] [Related]
4. Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through β-Catenin in Facioscapulohumeral Muscular Dystrophy.
Ganassi M; Figeac N; Reynaud M; Ortuste Quiroga HP; Zammit PS
Front Cell Dev Biol; 2022; 10():802573. PubMed ID: 36158201
[TBL] [Abstract][Full Text] [Related]
5. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
Gatica LV; Rosa AL
Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
[TBL] [Abstract][Full Text] [Related]
6. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.
Jones TI; King OD; Himeda CL; Homma S; Chen JC; Beermann ML; Yan C; Emerson CP; Miller JB; Wagner KR; Jones PL
Clin Epigenetics; 2015; 7(1):37. PubMed ID: 25904990
[TBL] [Abstract][Full Text] [Related]
7. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
Tassin A; Laoudj-Chenivesse D; Vanderplanck C; Barro M; Charron S; Ansseau E; Chen YW; Mercier J; Coppée F; Belayew A
J Cell Mol Med; 2013 Jan; 17(1):76-89. PubMed ID: 23206257
[TBL] [Abstract][Full Text] [Related]
8. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
Haynes P; Bomsztyk K; Miller DG
Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
[TBL] [Abstract][Full Text] [Related]
9. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions.
Statland JM; Tawil R
Curr Opin Neurol; 2011 Oct; 24(5):423-8. PubMed ID: 21734574
[TBL] [Abstract][Full Text] [Related]
10. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
[TBL] [Abstract][Full Text] [Related]
11. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
Richards M; Coppée F; Thomas N; Belayew A; Upadhyaya M
Hum Genet; 2012 Mar; 131(3):325-40. PubMed ID: 21984394
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.
Block GJ; Petek LM; Narayanan D; Amell AM; Moore JM; Rabaia NA; Tyler A; van der Maarel SM; Tawil R; Filippova GN; Miller DG
PLoS One; 2012; 7(4):e35532. PubMed ID: 22536400
[TBL] [Abstract][Full Text] [Related]
13. The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow.
de la Kethulle de Ryhove L; Ansseau E; Nachtegael C; Pieters K; Vanderplanck C; Geens M; Sermon K; Wilton SD; Coppée F; Lagneaux L; Belayew A
Stem Cells Dev; 2015 Nov; 24(22):2674-86. PubMed ID: 26192274
[TBL] [Abstract][Full Text] [Related]
14. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
Banerji CRS; Zammit PS
EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
[TBL] [Abstract][Full Text] [Related]
15. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.
Thijssen PE; Balog J; Yao Z; Pham TP; Tawil R; Tapscott SJ; Van der Maarel SM
Skelet Muscle; 2014; 4():19. PubMed ID: 25789155
[TBL] [Abstract][Full Text] [Related]
16. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
[TBL] [Abstract][Full Text] [Related]
17. A distal auxiliary element facilitates cleavage and polyadenylation of Dux4 mRNA in the pathogenic haplotype of FSHD.
Peart N; Wagner EJ
Hum Genet; 2017 Sep; 136(9):1291-1301. PubMed ID: 28540412
[TBL] [Abstract][Full Text] [Related]
18. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.
Ansseau E; Laoudj-Chenivesse D; Marcowycz A; Tassin A; Vanderplanck C; Sauvage S; Barro M; Mahieu I; Leroy A; Leclercq I; Mainfroid V; Figlewicz D; Mouly V; Butler-Browne G; Belayew A; Coppée F
PLoS One; 2009 Oct; 4(10):e7482. PubMed ID: 19829708
[TBL] [Abstract][Full Text] [Related]
19. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
Lemmers RJ; van der Vliet PJ; Balog J; Goeman JJ; Arindrarto W; Krom YD; Straasheijm KR; Debipersad RD; Özel G; Sowden J; Snider L; Mul K; Sacconi S; van Engelen B; Tapscott SJ; Tawil R; van der Maarel SM
Eur J Hum Genet; 2018 Jan; 26(1):94-106. PubMed ID: 29162933
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.
Himeda CL; Jones TI; Jones PL
Mol Ther; 2016 Mar; 24(3):527-35. PubMed ID: 26527377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
